Erforschen Sie relevante Themen über Hämatologie und Knochenmarktransplantation mit Experten der Escola Paulista de Medicina und des Hospital 9 de Julho.
49 - Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation
S1 E49 • 35 mins • Mar 18, 2025
Charts
- 173Increased by 20
- 200Decreased by 13
Neueste Folgen

Mar 18, 2025
49 - Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation
S1 E49 • 35 mins

Mar 16, 2025
48 - Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
S1 E48 • 27 mins

Mar 11, 2025
47 - Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
S1 E47 • 32 mins

Dec 29, 2024
46 - Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study
S1 E46 • 35 mins

Dec 26, 2024
45 - Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
S1 E45 • 31 mins

Sprache
Portugiesisch
Land
Brasilien
Feed Host
Website
Feed
Aktualisierung anfordern
Aktualisierungen können einige Minuten dauern.